Gepotidacin is as effective as nitrofurantoin in providing early symptom relief and clinical improvement in patients with ...

Blujepa is the first in a new class of oral antibiotics for uUTIs in nearly 30 years Over half of all women experience a uUTI in their lifetime, with approximately 30% suffering from a recurrent ...

After decades of losing ground to drug resistance, doctors finally have new weapons against gonorrhoea, a common sexually ...

The first new type of antibiotic developed in more than 20 years to treat urinary tract infections (UTIs) appears to be so effective that the pharmaceutical company stopped testing and will soon ...

The novel investigational oral antibiotic gepotidacin was efficacious and safe for the treatment of uncomplicated urinary tract infections, with activity against common uropathogens. Gepotidacin, a ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a new study finds. This could put the medication, called gepotidacin, on track ...

The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or uUTIs, successfully and safely. Gepotidacin will be marketed under the brand ...

The PDUFA target date was set for March 26, 2025. The Food and Drug Administration has granted Priority Review to gepotidacin for the treatment of female adult and adolescent patients aged 12 years ...

PHILADELPHIA, March 25, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of female ...